These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24691034)

  • 1. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
    Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
    PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
    McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
    J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of core DNA elements that target somatic hypermutation.
    Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
    J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attracting AID to targets of somatic hypermutation.
    Tanaka A; Shen HM; Ratnam S; Kodgire P; Storb U
    J Exp Med; 2010 Feb; 207(2):405-15. PubMed ID: 20100870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
    Yang SY; Fugmann SD; Schatz DG
    J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunoglobulin lambda light chain enhancer consists of three modules which synergize in activation of transcription.
    Asenbauer H; Combriato G; Klobeck HG
    Eur J Immunol; 1999 Feb; 29(2):713-24. PubMed ID: 10064089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Targets Somatic Hypermutation to the Immunoglobulin Loci?
    Heltzel JMH; Gearhart PJ
    Viral Immunol; 2020 May; 33(4):277-281. PubMed ID: 31770070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
    Tarsalainen A; Maman Y; Meng FL; Kyläniemi MK; Soikkeli A; Budzyńska P; McDonald JJ; Šenigl F; Alt FW; Schatz DG; Alinikula J
    J Immunol; 2022 Jan; 208(1):143-154. PubMed ID: 34862258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
    Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
    Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation.
    Inlay MA; Gao HH; Odegard VH; Lin T; Schatz DG; Xu Y
    J Immunol; 2006 Jul; 177(2):1146-51. PubMed ID: 16818772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical Mus musculus Igκ enhancers support transcription but not high level somatic hypermutation from a V-lambda promoter in chicken DT40 cells.
    Kothapalli NR; Norton DD; Fugmann SD
    PLoS One; 2011 Apr; 6(4):e18955. PubMed ID: 21533098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting.
    Dinesh RK; Barnhill B; Ilanges A; Wu L; Michelson DA; Senigl F; Alinikula J; Shabanowitz J; Hunt DF; Schatz DG
    Eur J Immunol; 2020 Mar; 50(3):380-395. PubMed ID: 31821534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IgH 3' regulatory region controls somatic hypermutation in germinal center B cells.
    Rouaud P; Vincent-Fabert C; Saintamand A; Fiancette R; Marquet M; Robert I; Reina-San-Martin B; Pinaud E; Cogné M; Denizot Y
    J Exp Med; 2013 Jul; 210(8):1501-7. PubMed ID: 23825188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
    Lin MM; Green NS; Zhang W; Scharff MD
    Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does somatic hypermutation by AID require transcription of its target genes?
    Storb U
    Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AID preferentially targets the top strand in nucleosome sequences.
    Singh AK; Jaiswal A; Kodgire P
    Mol Immunol; 2019 Aug; 112():198-205. PubMed ID: 31176199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: a cis-acting DNA element targets AID-mediated sequence diversification to the chicken Ig light chain gene locus.
    Kothapalli N; Norton DD; Fugmann SD
    J Immunol; 2008 Feb; 180(4):2019-23. PubMed ID: 18250404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
    Rückerl F; Busse B; Bachl J
    Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.